KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Assets (2016 - 2025)

Historic Assets for Dynavax Technologies (DVAX) over the last 17 years, with Q3 2025 value amounting to $946.5 million.

  • Dynavax Technologies' Assets fell 1087.43% to $946.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $946.5 million, marking a year-over-year decrease of 1087.43%. This contributed to the annual value of $986.3 million for FY2024, which is 108.72% down from last year.
  • Dynavax Technologies' Assets amounted to $946.5 million in Q3 2025, which was down 1087.43% from $918.4 million recorded in Q2 2025.
  • Dynavax Technologies' 5-year Assets high stood at $1.1 billion for Q3 2024, and its period low was $490.1 million during Q1 2021.
  • Over the past 5 years, Dynavax Technologies' median Assets value was $985.8 million (recorded in 2022), while the average stood at $939.6 million.
  • Per our database at Business Quant, Dynavax Technologies' Assets skyrocketed by 19417.73% in 2021 and then crashed by 1087.43% in 2025.
  • Dynavax Technologies' Assets (Quarter) stood at $1.0 billion in 2021, then decreased by 5.14% to $985.8 million in 2022, then grew by 1.14% to $997.1 million in 2023, then dropped by 1.09% to $986.3 million in 2024, then fell by 4.03% to $946.5 million in 2025.
  • Its Assets stands at $946.5 million for Q3 2025, versus $918.4 million for Q2 2025 and $945.9 million for Q1 2025.